• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人镰状细胞病延迟性溶血性输血反应:5 年经验。

Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.

机构信息

Molecular Haematology, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.

出版信息

Br J Haematol. 2015 Jun;169(5):746-53. doi: 10.1111/bjh.13339. Epub 2015 Mar 5.

DOI:10.1111/bjh.13339
PMID:25753472
Abstract

Delayed haemolytic transfusion reactions (DHTR) are potentially life-threatening complications in patients with sickle cell disease (SCD). Between 1 August 2008 and 31 December 2013, 220 of 637 adult patients in our centre had at least one red blood cell (RBC) transfusion in 2158 separate transfusion episodes. Twenty-three DHTR events occurred in 17 patients (13 female) including 15 HbSS, one HbSC and one HbSβ(0) thalassaemia, equating to a DHTR rate of 7·7% of patients transfused. Mean interval from RBC transfusion to DHTR event was 10·1 ± 5·4 d, and typical presenting features were fever, pain and haemoglobinuria. Twenty of the 23 (87·0%) DHTR episodes occurred following transfusion in the acute setting. Notably, 11/23 (47·8%) of DHTRs were not diagnosed at the time of the event, most were misdiagnosed as a vaso-occlusive crisis. 16/23 DHTRs had 'relative reticulocytopenia', which was more common in older patients. Seven of 23 episodes resulted in alloantibody formation, and three caused autoantibody formation. DHTRs are a severe but uncommon complication of RBC transfusion in SCD and remain poorly recognized, possibly because they mimic an acute painful crisis. Most of the DHTRs are triggered by RBC transfusion in the acute setting when patients are in an inflammatory state.

摘要

迟发性溶血性输血反应(DHTR)是镰状细胞病(SCD)患者潜在的危及生命的并发症。在 2008 年 8 月 1 日至 2013 年 12 月 31 日期间,我们中心的 637 名成年患者中有 220 名患者在 2158 次单独的输血事件中至少接受了一次红细胞(RBC)输血。在 17 名患者(13 名女性)中发生了 23 例 DHTR 事件,包括 15 例 HbSS、1 例 HbSC 和 1 例 HbSβ(0)地中海贫血,DHTR 发生率为接受输血的患者的 7.7%。从 RBC 输血到 DHTR 事件的平均间隔为 10.1±5.4d,典型的表现特征是发热、疼痛和血红蛋白尿。23 例 DHTR 中有 20 例(87.0%)发生在急性输血后。值得注意的是,11/23(47.8%)例 DHTR 在事件发生时未得到诊断,大多数被误诊为血管阻塞危象。23 例 DHTR 中有 16 例出现“相对网织红细胞减少症”,在老年患者中更为常见。7 例 DHTR 导致同种抗体形成,3 例导致自身抗体形成。DHTR 是 SCD 中 RBC 输血的严重但不常见的并发症,仍然认识不足,可能是因为它们类似于急性疼痛危机。大多数 DHTR 是在患者处于炎症状态的急性情况下由 RBC 输血引发的。

相似文献

1
Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.成人镰状细胞病延迟性溶血性输血反应:5 年经验。
Br J Haematol. 2015 Jun;169(5):746-53. doi: 10.1111/bjh.13339. Epub 2015 Mar 5.
2
How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.如何治疗镰状细胞病患者的迟发性溶血性输血反应。
Br J Haematol. 2015 Sep;170(6):745-56. doi: 10.1111/bjh.13494. Epub 2015 May 13.
3
Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.镰状细胞病患儿的迟发性溶血性输血反应/高溶血综合征
Pediatrics. 2003 Jun;111(6 Pt 1):e661-5. doi: 10.1542/peds.111.6.e661.
4
Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.扩展表型分析并不能排除镰状细胞病迟发性溶血性输血反应的发生。
Br J Haematol. 2022 Feb;196(3):769-776. doi: 10.1111/bjh.17875. Epub 2021 Oct 10.
5
Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.成人镰状细胞病中的迟发性溶血性输血反应:99 例转诊中心病例的表现、结局和治疗。
Am J Hematol. 2016 Oct;91(10):989-94. doi: 10.1002/ajh.24460. Epub 2016 Jul 14.
6
Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.成人镰状细胞病患者迟发性溶血性输血反应的发生率和预测评分。
Am J Hematol. 2017 Dec;92(12):1340-1348. doi: 10.1002/ajh.24908. Epub 2017 Oct 31.
7
Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.镰状细胞病患者的同种免疫反应和伴随的迟发性溶血性输血反应的漏诊。
Transfusion. 2019 Jul;59(7):2282-2291. doi: 10.1111/trf.15328. Epub 2019 Apr 25.
8
Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.镰状细胞病患者发生同种免疫和迟发性溶血性输血反应的风险。
Arch Intern Med. 1988 Nov;148(11):2485-9.
9
Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).迟发性溶血性输血反应(DHTR)中的免疫血液学发现。
Transfus Clin Biol. 2019 May;26(2):102-108. doi: 10.1016/j.tracli.2019.02.006. Epub 2019 Feb 22.
10
Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.镰状细胞病患者的迟发性溶血性输血反应:一种以自杀性红细胞死亡为特征的新兴综合征的证据。
Transfusion. 2009 Sep;49(9):1785-92. doi: 10.1111/j.1537-2995.2009.02199.x. Epub 2009 Apr 28.

引用本文的文献

1
Alloimmunization and consequential delayed hemolytic transfusion reactions in sickle cell disease patients: A case series.镰状细胞病患者的同种免疫及相应的迟发性溶血性输血反应:病例系列
Asian J Transfus Sci. 2025 Jan-Jun;19(1):167-172. doi: 10.4103/ajts.ajts_191_23. Epub 2024 Oct 5.
2
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature.镰状细胞病中高溶血的应对策略:文献综述
Diagnostics (Basel). 2025 Jul 21;15(14):1835. doi: 10.3390/diagnostics15141835.
3
CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion.
CD47在不相容输血后调节抗原调节和红细胞清除。
Front Immunol. 2025 Apr 4;16:1548548. doi: 10.3389/fimmu.2025.1548548. eCollection 2025.
4
Clinics and genetics of hyperhemolysis syndrome in patients with sickle cell disease.镰状细胞病患者高溶血综合征的临床特征与遗传学研究
Transfusion. 2025 May;65(5):992-1000. doi: 10.1111/trf.18232. Epub 2025 Apr 2.
5
Harnessing the potential of red blood cells in immunotherapy.挖掘红细胞在免疫治疗中的潜力。
Hum Immunol. 2024 Nov;85(6):111084. doi: 10.1016/j.humimm.2024.111084. Epub 2024 Sep 9.
6
Investigation of Delayed Transfusion Reactions in Sickle Cell Disease Patients Polytransfused in the Brazilian Amazon.巴西亚马逊地区多次输血的镰状细胞病患者迟发性输血反应的调查。
Hematol Rep. 2024 Aug 1;16(3):512-522. doi: 10.3390/hematolrep16030049.
7
A genome-wide association study of alloimmunization in the TOPMed OMG-SCD cohort identifies a locus on chromosome 12.一项针对 TOPMed OMG-SCD 队列中同种免疫的全基因组关联研究确定了 12 号染色体上的一个位点。
Transfusion. 2024 Sep;64(9):1772-1783. doi: 10.1111/trf.17944. Epub 2024 Jul 5.
8
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series.依库珠单抗治疗小儿镰状细胞病高溶血性综合征:单中心病例系列。
Pediatr Blood Cancer. 2024 Aug;71(8):e31061. doi: 10.1002/pbc.31061. Epub 2024 Jun 5.
9
Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.溶血驱动的 IFNα 产生通过负向调节镰状细胞病中的 EPO 信号转导来损害红细胞生成。
Blood. 2024 Mar 14;143(11):1018-1031. doi: 10.1182/blood.2023021658.
10
Alloimmunization and hyperhemolysis in sickle cell disease.镰状细胞病中的同种免疫与高红细胞溶血。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):653-659. doi: 10.1182/hematology.2023000499.